EDWARD N. DEAN, MD

BILLINGS, MT

Research Active
Internal Medicine - Interventional Cardiology NPI registered 21+ years 50 publications 2024 – 2026 NPI: 1659376135
NeoplasmsExerciseThrombosisAntineoplastic Combined Chemotherapy ProtocolsDietAustraliaSmoking CessationPyrimidinesSulfonamidesAtaxia Telangiectasia Mutated ProteinsQuality Assurance, Health CareMorpholinesMaximum Tolerated DoseBlood Coagulation TestsIndoles

Practice Location

2900 12TH AVE N
BILLINGS, MT 59101-0164

Phone: (406) 237-5001

What does EDWARD DEAN research?

Dr. Dean studies the effectiveness of advanced treatment options for cancers such as melanoma, lung cancer, prostate cancer, and head and neck cancer. He particularly investigates novel drugs like ceralasertib and olaparib to find better combinations that can lead to positive responses in patients who have not benefitted from standard therapies. In addition to cancer treatment, he explores the impact of physical health, like exercise and nutrition, on managing conditions such as depression and the complexities of pain management following surgery, focusing on how existing medications like opioids are used and perceived by patients.

Key findings

  • In a study of patients with advanced melanoma, only 9.3% responded to a combination of ceralasertib and durvalumab, while 5.8% responded to ceralasertib alone, indicating low effectiveness of treatments for resistant cases.
  • In the Phase 1 study for lung cancer, out of 60 patients treated with ceralasertib and durvalumab, 8.3% showed a positive treatment response, with 98.3% experiencing some side effects.
  • In a study on opioid use following surgery for spinal injuries, opioid use decreased from 89.4% at discharge to 23.2% by the final follow-up, indicating improvements in pain management strategies.

Frequently asked questions

Does Dr. Dean study cancer treatment?
Yes, Dr. Dean conducts research on advanced treatment options for various cancers, including melanoma, lung cancer, prostate cancer, and head and neck cancer.
What treatments has Dr. Dean researched?
Dr. Dean has researched drugs like ceralasertib and olaparib, often in combination with other therapies, to improve outcomes for cancer patients who do not respond to standard treatments.
Is Dr. Dean's work relevant to patients with chronic pain?
Yes, he investigates pain management strategies, including the use of opioids after surgery for spinal injuries, to understand better ways to support patient recovery and manage acute pain.
What does Dr. Dean's research say about nutrition and exercise for managing depression?
His research emphasizes that adopting a healthy diet and engaging in aerobic exercise are essential components of managing depression, alongside traditional therapies.
How does Dr. Dean's work help patients with hemophilia?
He has studied the accuracy of laboratory measurements for Factor VIII levels essential for treating hemophilia A, highlighting the need for better practices to ensure patients receive the correct treatment.

Publications in plain English

Comparative effects of a glucose-fructose bar, glucose-fructose hydrogel and maltodextrin gel on carbohydrate oxidation and sprint performance in Tier 2 athletes.

2026

Experimental physiology

Dean E, Osborne A, Subar D, Hendrickse P, Gaffney CJ

Plain English
This study looked at how three different sports drinks affected energy usage and sprint performance in semi-professional athletes. The results showed that the glucose-fructose bar helped athletes burn more carbs (about 24.6 grams) compared to the maltodextrin gel (17.8 grams), but all three supplements produced similar results in sprinting performance and how athletes felt afterward. This is important because it means athletes can choose any of these supplements without worrying about their impact on high-intensity exercise. Who this helps: Athletes looking for effective carbohydrate supplements during training and competition.

PubMed

Performance of Factor VIII Extended Half-Life Product Measurements in External Quality Assessment Programmes.

2026

International journal of laboratory hematology

Williams A, Meijer P, Dean E, Reilly-Stitt C, Kitchen S +2 more

Plain English
This study looked at how well different laboratories measure Factor VIII (FVIII) levels, which are crucial for treating patients with hemophilia A. In 2023, researchers evaluated FVIII results from 37 laboratories using five different treatment products. They found that many laboratories struggled to produce consistent measurements, with some reporting too low and others too high results, which could lead to patients receiving incorrect treatment. Who this helps: This helps patients with hemophilia A by highlighting the need for better lab practices to ensure accurate treatment.

PubMed

"I want my students to feel supported"-the foundation doctor taking time out of training to teach.

2026

BMJ (Clinical research ed.)

Dean E

PubMed

The GP using poetry to connect with creative medics and find catharsis.

2026

BMJ (Clinical research ed.)

Dean E

PubMed

Phase 1 study of ceralasertib, an ATR kinase inhibitor, in combination with durvalumab in patients with recurrent or metastatic NSCLC or HNSCC.

2026

British journal of cancer

Lopez JS, Harrington KJ, Im SA, Lee KW, Postel-Vinay S +10 more

Plain English
This study looked at combining two drugs, ceralasertib and durvalumab, to see how safe and effective they are for patients with advanced lung cancer or head and neck cancer. Out of 60 patients, most (98.3%) experienced some side effects, with a few having serious issues like low blood cell counts. However, 8.3% of patients showed a positive response to the treatment, and over half had stable disease, meaning their cancer didn’t get worse. Who this helps: This benefits patients with advanced non-small-cell lung cancer and head and neck squamous cell carcinoma.

PubMed

Mental health in mosques: the GP tackling the unmet needs of Muslim patients.

2026

BMJ (Clinical research ed.)

Dean E

PubMed

Authors reply to: Interpreting whole-body carbohydrate oxidation and 'oxidation efficiency' in carbohydrate supplement studies.

2026

Experimental physiology

Dean E, Osbrone A, Subar D, Hendrickse P, Gaffney CJ

PubMed

MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition.

2026

Clinical cancer research : an official journal of the American Association for Cancer Research

Schlaak M, Cimminiello C, Pigozzo J, Lee J, Grabbe S +16 more

Plain English
This study looked at the effectiveness of a drug called ceralasertib, both alone and combined with another drug, durvalumab, in treating advanced melanoma that did not respond to prior immunotherapy. The results showed that only 9.3% of patients responded to the combination treatment, while 5.8% responded to ceralasertib alone, with median survival times of about 16 months and 12.3 months, respectively. These findings highlight that both treatment options had low response rates for patients who previously didn't respond to other therapies, indicating a need for better treatment strategies. Who this helps: This research helps doctors and researchers looking for better treatments for patients with resistant melanoma.

PubMed

The control of prickle formation in.

2026

bioRxiv : the preprint server for biology

Aubin BS, Poorten T, Fister A, Ochsenfeld C, Reiner J +23 more

Plain English
Researchers studied how to reduce the prickles on blackberry and raspberry plants, which make handling and harvesting difficult and increase costs for farmers. They discovered specific genetic changes that can eliminate these prickles without affecting other important traits in the plants. By using gene editing, they successfully created prickless versions of elite blackberry varieties, streamlining the breeding process and making these crops easier to manage. Who this helps: This benefits farmers and growers by providing them with easier-to-harvest plant varieties.

PubMed

Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessment Providers-for the External Quality Assurance in Thrombosis and Haemostasis Group.

2025

Seminars in thrombosis and hemostasis

Jennings I, Meijer P, Arunachalam S, Marlar RA, Olson JD +11 more

Plain English
This study looked at how different laboratories perform tests related to blood clotting by using a specific plasma sample as a standard. Researchers collected results from six different quality assessment providers, totaling over 1,250 test results. They found that most tests reported results very close to the expected values, showing that combining data from multiple labs can give more reliable results, especially for tests that not many labs perform. Who this helps: This benefits laboratories and healthcare providers who conduct blood clotting tests.

PubMed

Status of animal experimentation in nutrition and dietetic research: Policies of 100 leading journals and new approach methodologies.

2025

Accountability in research

Storz MA, Dean E

Plain English
This research looked at how 100 top nutrition and diet journals handle animal testing and whether they are using alternative methods. The findings showed that only 9.6% of journals refuse to publish animal studies, while 85.5% still publish them without restrictions. This matters because using alternative approaches could lead to better results for human health and reduce the ethical issues surrounding animal research. Who this helps: Patients and healthcare providers looking for more relevant nutrition research.

PubMed

Impact of Antidepressant Use on Intraoperative Blood Loss and Transfusion Rates in Lumbar Fusion Surgery.

2025

World neurosurgery

McCurdy M, Narayanan R, Dalton J, Herczeg CK, Heard J +14 more

Plain English
This study looked at how taking antidepressants affects bleeding during lumbar fusion surgery, a common spine procedure. Researchers compared 420 patients who were on antidepressants with 420 who were not. They found that those taking antidepressants did not experience more bleeding or need more blood transfusions during or after surgery, which means there’s no need to stop these medications before the procedure. Who this helps: This helps patients who take antidepressants and need lumbar fusion surgery.

PubMed

Medical apprenticeships: what next now that the scheme has been paused?

2025

BMJ (Clinical research ed.)

Dean E

PubMed

Activated Protein C Resistance Testing: An Update From Australasia/Asia-Pacific.

2025

International journal of laboratory hematology

Favaloro EJ, Arunachalam S, Dean E, Salwa M, Ahuja M +4 more

Plain English
This research looked at Activated Protein C Resistance (APCR) testing, which helps doctors understand the risk of blood clots in patients. Over 13 years, including a recent focus from 2020 to 2023, results showed that different testing methods had inconsistent accuracy, with the best performers being the Pefakit and Staclot methods. This matters because improving the reliability of these tests can help prevent serious complications from blood clots in patients. Who this helps: This helps patients at risk for blood clots and their doctors.

PubMed

Paying it forward: the consultant psychiatrist.

2025

BMJ (Clinical research ed.)

Dean E

PubMed

Smoking and Complications After Cancer Surgery: A Systematic Review and Meta-Analysis.

2025

JAMA network open

Wong C, Mohamad Asfia SKB, Myles PS, Cunningham J, Greenhalgh EM +5 more

Plain English
This study examined how smoking affects complications that can occur after cancer surgery. Researchers found that people who smoked within four weeks before their surgery had a 31% higher chance of complications compared to those who stopped smoking for at least that long. Additionally, those who had never smoked faced nearly three times the risk of complications compared to current smokers. This information is important for doctors to consider when deciding whether to delay surgery for patients who smoke. Who this helps: This helps patients undergoing cancer surgery and their doctors.

PubMed

Exploring prehabilitation interventions for patients with gynaecological cancer undergoing radiotherapy: A scoping review.

2025

PloS one

McGladrigan E, Wrench E, Dean E, O'Neil A, Ashmore L +1 more

Plain English
This study looked at how prehabilitation, which prepares cancer patients for treatment, can help those with gynaecological cancers undergoing radiotherapy. Researchers reviewed 90 articles and found that while most studies focused on nutrition, psychological support, and exercise, there were very few comprehensive programs combining these approaches. It's important to improve these prehabilitation strategies to better support patients' physical and mental health during treatment. Who this helps: This benefits patients with gynaecological cancers and their healthcare providers.

PubMed

Optimization of the Care4Today Digital Health Platform to Enhance Self-Reporting of Medication Adherence and Health Experiences in Patients With Coronary or Peripheral Artery Disease: Mixed Methods Study.

2025

JMIR cardio

Juan S, Harxhi A, Kaul S, Woods B, Tran M +5 more

Plain English
This study looked at the Care4Today digital health platform, which helps patients with heart-related diseases like coronary artery disease (CAD) and peripheral artery disease (PAD) track their medication and health experiences. Researchers gathered feedback from patients through surveys and discussions and found that 89% felt confident using the app after a tutorial. They identified two key improvements for the app: automatically tracking medication data and getting feedback from healthcare teams on their health reports, making it easier for patients to manage their conditions. Who this helps: Patients with coronary or peripheral artery disease.

PubMed

Why I . . . write crosswords.

2025

BMJ (Clinical research ed.)

Dean E

PubMed

The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study.

2025

British journal of cancer

Yap TA, LoRusso P, Miller RE, Kristeleit R, Paulovich AG +10 more

Plain English
This study looked at a new cancer treatment called AZD7648, alone and with another drug, pegylated liposomal doxorubicin (PLD), in patients with advanced cancer. Out of 30 patients, many experienced side effects, particularly stomach problems (64% with AZD7648 alone and 81% with the combination), and there was limited success in shrinking tumors, with only one patient showing a partial response. The high level of toxicity and low effectiveness led to stopping the study early. Who this helps: This research informs doctors and researchers about potential risks and limited benefits for patients with advanced cancer.

PubMed

Thoracic Society of Australia and New Zealand (TSANZ) Guidance for the Management of Electronic Cigarette Use (Vaping) in Adolescents and Adults.

2025

Respirology (Carlton, Vic.)

Marshall H, Vandeleur M, Dean E, Barton C, Luxton N +9 more

Plain English
This paper looks at the growing use of electronic cigarettes (vaping) among young people in Australia and New Zealand and outlines guidance for doctors on how to manage vaping in patients. The authors found that while vaping is increasing rapidly and has potential health risks, there isn’t enough solid research to firmly support how to help people quit. They provide advice on preventing young people from starting to vape and how to help both new and long-term users stop, highlighting an urgent need for more focused research on quitting vaping. Who this helps: This guidance helps doctors and healthcare providers working with patients who use e-cigarettes.

PubMed

Patient Perceptions on Opioid Therapy for Acute Pain Management in the Emergency Department and Post-Surgical Settings: A Qualitative Study.

2025

Journal of pain research

Lucey E, Dean E, Chapman BP, Perugini R, Chai P +2 more

Plain English
This study explored patients' experiences with opioid therapy for managing acute pain in emergency and surgical settings. Researchers conducted interviews with 44 patients, revealing that many felt confused and wanted better information about their treatment. Some patients experienced withdrawal and dependence symptoms, even after only short-term use. Understanding these experiences is crucial to improve patient education and care strategies regarding opioid therapy. Who this helps: This research helps patients and healthcare providers by highlighting the need for better communication and support around opioid use.

PubMed

Why I . . . quilt.

2025

BMJ (Clinical research ed.)

Dean E

PubMed

Biochemical Reference Intervals of Free-Ranging Koalas (Phascolarctos cinereus) in South Australia.

2025

Veterinary clinical pathology

Font MB, Woolford L, Jaensch S, Hayward D, Hebart M +5 more

Plain English
This study looked at the blood chemistry of healthy koalas in South Australia to create reference values that can help assess their health. Researchers analyzed samples from 206 koalas and found that factors like age and certain infections impacted their blood chemistry. For example, differences related to age were observed in levels of alkaline phosphatase and phosphate, which are linked to bone growth, while glucose and gamma glutamyl transferase levels showed minor differences due to infections. Who this helps: This information benefits veterinarians and wildlife researchers who monitor koala health.

PubMed

Combined Transosseous and Osteosynthetic Reconstruction of Chronic Patellar Tendon Rupture Using Achilles Tendon Allograft With Bone Block.

2025

Arthroscopy techniques

Maier S, Dean E, Pikowski M, Jackson E

Plain English
This study looked at a new surgical method for fixing chronic tears in the patellar tendon, which can cause serious pain and limit movement. Researchers used a donated Achilles tendon combined with a bone block and found that their technique will help avoid common pitfalls of surgery, like irritating hardware and improper healing. This matters because it offers a better way to restore function and reduce pain for patients who suffer from these tendon injuries. Who this helps: This helps patients with chronic patellar tendon tears.

PubMed

Why I . . . teach piano.

2025

BMJ (Clinical research ed.)

Dean E

PubMed

Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial.

2025

Nature communications

Dillon MT, Patin EC, Mohammed K, Guevara J, Smith SA +16 more

Plain English
Researchers studied the effects of combining a drug called ceralasertib, which inhibits a protein involved in cancer growth, with palliative radiotherapy in patients. They found that out of 23 patients who could be evaluated for effectiveness, 2 had complete tumor shrinkage, 6 had partial shrinkage, and 13 showed stable disease, while only 2 experienced worsening tumors. This combination treatment helped activate the immune system, which is important because it could enhance how the body fights cancer. Who this helps: This benefits cancer patients, particularly those receiving palliative care.

PubMed

"I was suicidal"-the consultant psychiatrist opening up the conversation on postnatal depression.

2025

BMJ (Clinical research ed.)

Dean E

PubMed

Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP).

2025

JCO precision oncology

Tsung I, Smith DC, Heath EI, Cackowski F, Devitt ME +12 more

Plain English
This study looked at how effective the combination of two drugs, olaparib and ceralasertib, is for treating advanced prostate cancer that doesn't respond to standard hormone therapies. They found that only 11% of patients without certain genetic mutations (HRP) and 33% of those with genetic mutations (HRRm) responded to the treatment, with an average period of about 8.2 months before the disease progressed. This is important because it suggests that this specific drug combination may not be much better than previous treatments using just one drug. Who this helps: This research helps oncologists and patients with metastatic castration-resistant prostate cancer understand the effectiveness of this treatment combination.

PubMed

Post-operative opioid utilization after surgery for spinal trauma: a retrospective study at a level 1 trauma center.

2025

Journal of spine surgery (Hong Kong)

Rajan PV, Dean E, Milby AH

Plain English
This study examined how different factors influence opioid use after surgery for spinal injuries. Researchers looked at 109 patients and found that opioid use decreased significantly, from 89.4% at discharge to 23.2% by final follow-up. However, patients with incomplete spinal cord injuries and partial recovery were more likely to continue using opioids longer, while older patients and those with cervical injuries had better chances of reducing their opioid intake. Who this helps: This research benefits both patients recovering from spinal injuries and their doctors by providing insights for better pain management strategies.

PubMed

Advancing Inclusive Research in Intellectual and Developmental Disabilities: Building Community and Supports for Participation.

2025

Intellectual and developmental disabilities

Shogren KA, Linnenkamp B, Townsend R, Edwards B, Rentschler L +8 more

Plain English
This study looked at how people with intellectual and developmental disabilities are often left out of research processes and why that needs to change. The researchers identified that, even with a push for more inclusive practices over the last ten years, these methods are still not widely used. They outlined specific actions taken to empower these individuals to participate in research, emphasizing the importance of making systemic changes to ensure their inclusion. Who this helps: This benefits individuals with intellectual and developmental disabilities and the researchers who study them.

PubMed

"I always make a deliberate mistake"-knitting as an antidote to perfectionism.

2025

BMJ (Clinical research ed.)

Dean E

PubMed

Secular Trend Analysis of NHANES Data Suggests Only Modest Increases in Health-Related Lifestyle Advice Delivered by Health Professionals.

2025

Inquiry : a journal of medical care organization, provision and financing

Storz MA, Dean E

Plain English
This study looked at how often health professionals in the U.S. give advice about healthy lifestyles to their patients from 2011 to 2018. It found that only about 25% of people received advice to reduce salt intake, 40% were encouraged to exercise, and 30% were told to cut back on fat and calories. Although there were slight increases in the number of patients receiving this advice over the years, the overall delivery of such recommendations was still low and needs improvement because promoting healthy lifestyles is just as important as prescribing medication. Who this helps: Patients looking to improve their health and manage chronic diseases.

PubMed

Priority of nutrition and exercise in depression management: triangulating mini-review of past and recent evidence with clinical practice guidelines.

2025

Journal of health, population, and nutrition

Rogers S, Dean E

Plain English
This study looked at how nutrition and exercise can help manage depression. Researchers found that a large majority—68%—of studies on diet recommended anti-inflammatory, whole food, plant-based diets, while 89% of studies on exercise emphasized the importance of aerobic activities. The findings suggest that these healthier lifestyle choices should be included more prominently in depression treatment guidelines, alongside medications and therapy. Who this helps: This helps patients with depression by offering them additional strategies for management.

PubMed

Relationship Between Preoperative Pfirrmann Grading and Adjacent Segment Degeneration After Anterior Cervical Diskectomy and Fusion.

2025

The Journal of the American Academy of Orthopaedic Surgeons

Dalton JF, Oris RJ, Mathew J, McCurdy MA, Alexander T +20 more

Plain English
This study looked at how the condition of the discs next to the ones being operated on can impact recovery after neck surgery, specifically anterior cervical decompression and fusion. Researchers found that patients with higher degeneration grades in their adjacent discs (Pfirrmann grades III and IV) had a significant decrease in disk height two years after the surgery. This means that if a patient's disc health is poor before surgery, it can lead to more serious issues after surgery, though the rate of needing follow-up surgeries remains the same after five years. Who this helps: This information helps patients and doctors by providing insights on the importance of assessing disc health prior to neck surgery.

PubMed

Follow-up of women with cervical adenocarcinoma in situ treated by conization: A single centre clinical experience.

2024

Gynecologic oncology

Adolph L, Mann A, Liu XQ, Roberts L, Robinson C +5 more

Plain English
This study looked at how well women with a condition called adenocarcinoma in situ (AIS) in the cervix did when treated with a procedure called conization, which preserves fertility. Researchers reviewed the medical records of 121 women treated from 2006 to 2020 and found that only 5% of them experienced a recurrence of the condition, with just one case turning into cancer. This shows that conization followed by careful monitoring is a safe treatment option, meaning that many women can avoid a hysterectomy, which is a major surgery that removes the uterus. Who this helps: This helps women with AIS, especially those who want to keep their ability to have children.

PubMed

Why I . . . make free flight aircraft.

2024

BMJ (Clinical research ed.)

Dean E

PubMed

Patient safety commissioner: "A relentless focus on NHS finance and productivity is failing patient safety".

2024

BMJ (Clinical research ed.)

Dean E

PubMed

The role of general practice nurses in supporting people to quit smoking: A qualitative study.

2024

PloS one

Jongebloed H, Cole E, Dean E, Ugalde A

Plain English
This study looked at how nurses in Australian general practices help patients quit smoking. Researchers interviewed 14 nurses and found that while nurses are ready to assist patients, they face challenges like unclear roles and varying support systems in their clinics. It's important because enhancing nurses' involvement in smoking cessation can improve care for patients trying to quit. Who this helps: Patients trying to quit smoking, especially in general practice settings.

PubMed

Discovery andEfficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity.

2024

Journal of medicinal chemistry

Smith JM, Barlaam B, Beattie D, Bradshaw L, Chan HM +37 more

Plain English
This study focused on a new drug called AZ-PRMT5i-1, which targets a protein linked to cancer growth. Researchers found that this drug is very effective, working at concentrations below 10 nanomoles and showing more than 50 times the effectiveness in cancers lacking a specific protein (MTAP). This is important because it could lead to better treatment options for certain cancer patients who currently have no effective therapies. Who this helps: Patients with MTAP-deficient cancers.

PubMed

Open-Source Approach to GPU-Accelerated Substructure Search.

2024

Journal of chemical information and modeling

Whitehouse AJ, Sanchez-Martinez M, Salehi SM, Kurbatova N, Dean E

Plain English
This study looked at how to improve the process of searching for specific chemical structures within large databases, which is important for developing new drugs. By using advanced computer technology (GPU acceleration), researchers were able to make searches faster and more efficient. These advancements are significant because they will help scientists find potential drug candidates more quickly and effectively. Who this helps: This benefits scientists and researchers in drug development.

PubMed

Maintaining a personal identity: the consultant radiologist.

2024

BMJ (Clinical research ed.)

Dean E

PubMed

The physician associates becoming doctors.

2024

BMJ (Clinical research ed.)

Dean E

PubMed

An unbiased, sustainable, evidence-informed Universal Food Guide: a timely template for national food guides.

2024

Nutrition journal

Dean E, Xu J, Jones AY, Vongsirinavarat M, Lomi C +3 more

Plain English
This study created a new Universal Food Guide to help countries develop their own food guidelines based on sound science rather than corporate or political interests. The research showed that a plant-based diet, particularly vegan, is the healthiest option and can significantly reduce the risk of chronic diseases. This is important because current food guides often reflect non-scientific influences that can lead to health problems and environmental damage. Who this helps: This helps patients, health professionals, and policy makers by providing clear, unbiased dietary guidelines.

PubMed

Building relationships with patients and their families: the consultant in rehabilitation medicine.

2024

BMJ (Clinical research ed.)

Dean E

PubMed

Conscientious objection: will doctors be able to opt out of assisted dying?

2024

BMJ (Clinical research ed.)

Dean E

PubMed

Correction: An unbiased, sustainable, evidence-informed Universal Food Guide: a timely template for national food guides.

2024

Nutrition journal

Dean E, Xu J, Jones AY, Vongsirinavarat M, Lomi C +3 more

PubMed

Training shouldn't be purgatory: the consultant cardiologist.

2024

BMJ (Clinical research ed.)

Dean E

PubMed

Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacy.

2024

Frontiers in oncology

Balagurunathan Y, Wei Z, Qi J, Thompson Z, Dean E +8 more

Plain English
This study looked at how certain characteristics of tumors visible in PET/CT scans can predict how well patients with a type of lymphoma called diffuse large B cell lymphoma (DLBCL) will respond to a specific treatment called CAR T cell therapy. It found that the shape of the largest tumor lesions, as well as the overall tumor volume, were good indicators of survival; in fact, a combination of these features predicted a 1-year survival rate with an accuracy of 78%. This matters because it helps doctors determine which patients are more likely to benefit from this immunotherapy, potentially leading to better treatment decisions. Who this helps: Patients with relapsed or refractory diffuse large B cell lymphoma.

PubMed

Future of England's medical apprenticeships is in doubt as pilot schemes are put on hold.

2024

BMJ (Clinical research ed.)

Dean E

PubMed

Frequent Co-Authors

Daren Subar Paul Hendrickse Christopher J Gaffney Kevin J Harrington Piet Meijer Ian Jennings Isobel D Walker Rajkishen Narayanan Yunsoo Lee Jose A Canseco

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.